Patents Assigned to Vida Pharma Limited
  • Treatment of energy utilization disease
    Patent number: 10842784
    Abstract: Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: November 24, 2020
    Assignee: Vida Pharma Limited
    Inventors: Robert James Nash, Francis Xavier Wilson, Graeme Horne